select trial semaglutide nejm was published today in NEJM. Below, I summarize the trial and the drug in this thread.... - Dr Shailesh Singh In the SURMOUNT-5 phase 3b

Pregnancy, breastfeeding, and active gallbladder disease are listed as warranting a detailed risk-benefit discussion before starting

Complete resolution typically occurs within 48 weeks as your digestive system adapts to the medication's effects on stomach emptying and satiety signaling

Children with craniopharyngioma, a rare type of tumor, may also show symptoms that resemble Prader-Willi syndrome

One-carbon metabolism supports S-adenosylmethionine and histone methylation to drive inflammatory macrophages

Article 7 mins How to Navigate AI-Driven Cyber Risks Business leaders are aware of AI-driven cyber risks and their implications

Peptides are short chains of amino acids that serve as signaling molecules throughout the body